A Population-Based Study of Recurrent Symptomatic Bordetella pertussis Infections in Children in California, 2010–2015
Author(s) -
Lauren Platt,
Melissa Thun,
Kathleen Harriman,
Kathleen Winter
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix691
Subject(s) - medicine , bordetella pertussis , pediatrics , pertussis vaccine , whooping cough , population , diphtheria , immunity , immunology , vaccination , immunization , immune system , environmental health , bacteria , biology , genetics
Natural infection with Bordetella pertussis is thought to result in 4-20 years of immunity against subsequent symptomatic pertussis infection. However, these estimates are based on studies in unvaccinated or whole-cell pertussis-vaccinated children. We conducted a population-based study of pertussis infection and reinfection during a 5-year period in California in an cohort vaccinated exclusively with acellular pertussis (aP) vaccine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom